These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2147199)

  • 1. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.
    Kalish RS; Johnson KL
    J Immunol; 1990 Dec; 145(11):3706-13. PubMed ID: 2147199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.
    Kalish RS; Morimoto C
    J Clin Invest; 1988 Sep; 82(3):825-32. PubMed ID: 2458387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.
    Kalish RS; Wood JA; LaPorte A
    J Clin Invest; 1994 May; 93(5):2039-47. PubMed ID: 7910172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.
    Kalish RS
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):108S-111S. PubMed ID: 1693644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.
    Kalish RS; Morimoto C
    J Invest Dermatol; 1989 Jan; 92(1):46-52. PubMed ID: 2521239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model system for contact sensitization to poison oak or ivy urushiol components.
    Dunn IS; Liberato DJ; Dennick RG; Castagnoli N; Byers VS
    Cell Immunol; 1982 Apr; 68(2):377-88. PubMed ID: 6178516
    [No Abstract]   [Full Text] [Related]  

  • 10. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hapten-specific tolerance of human CD8+ urushiol (poison ivy)-reactive T lymphocytes.
    Kalish RS; Wood JA
    J Invest Dermatol; 1997 Mar; 108(3):253-7. PubMed ID: 9036920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
    Long D; Ballentine NH; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
    Alé SI; Ferreira F; González G; Epstein W
    Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide:hapten conjugate.
    Gelber C; Gemmell L; McAteer D; Homola M; Swain P; Liu A; Wilson KJ; Gefter M
    J Immunol; 1997 Mar; 158(5):2425-34. PubMed ID: 9036993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the pathogenesis of allergic contact dermatitis.
    Kalish RS
    Arch Dermatol; 1991 Oct; 127(10):1558-63. PubMed ID: 1929465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyposensitization to poison ivy after working in a cashew nut shell oil processing factory.
    Reginella RF; Fairfield JC; Marks JG
    Contact Dermatitis; 1989 Apr; 20(4):274-9. PubMed ID: 2526711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling reveals Th2 bias and identifies endogenous itch mediators in poison ivy contact dermatitis.
    Liu B; Tai Y; Liu B; Caceres AI; Yin C; Jordt SE
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the mango-poison ivy connection: the riddle of discriminative plant dermatitis.
    Hershko K; Weinberg I; Ingber A
    Contact Dermatitis; 2005 Jan; 52(1):3-5. PubMed ID: 15701120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.